PLA2G6

85/88 kDa calcium-independent phospholipase A2 · O60733 · PLA2G6 on Sugi Atlas →

4,126 patent compounds predicted against PLA2G6, 2,305 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Bromoenol Lactone Bromoenol Lactone (SCHEMBL2060001) 1.00 4/20
Bromoenol Lactone Bromoenol Lactone (SCHEMBL2060073) 1.00 4/20
Bromoenol Lactone Bromoenol Lactone (SCHEMBL2060074) 1.00 4/20
SCHEMBL3296491 SCHEMBL3296491 1.00 4/20
SCHEMBL3296494 SCHEMBL3296494 1.00 4/20
SCHEMBL3296498 SCHEMBL3296498 1.00 4/20
(S)-Bromoenol Lactone (S)-Bromoenol Lactone (SCHEMBL3298296) 1.00 4/20
Bromoenol Lactone Bromoenol Lactone (SCHEMBL3302140) 1.00 4/20
Bromoenol Lactone Bromoenol Lactone (SCHEMBL3302144) 1.00 4/20
SCHEMBL2433362 SCHEMBL2433362 0.54 4/20
SCHEMBL2433365 SCHEMBL2433365 0.54 4/20
SCHEMBL2433366 SCHEMBL2433366 0.54 4/20
SCHEMBL2423747 SCHEMBL2423747 0.51 4/20
SCHEMBL2423749 SCHEMBL2423749 0.51 4/20
SCHEMBL4802338 SCHEMBL4802338 0.50 4/20
SCHEMBL4800917 SCHEMBL4800917 0.49 4/20
SCHEMBL2083374 SCHEMBL2083374 0.49 4/20
SCHEMBL576000 SCHEMBL576000 0.46 4/20
SCHEMBL657069 SCHEMBL657069 0.44 4/20
SCHEMBL576081 SCHEMBL576081 0.44 4/20

Clinical trials — most relevant to PLA2G6 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL) PHASE4COMPLETED
Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study PHASE4COMPLETED
Diet Rich in N-3 Polyunsaturated Fatty Acids in Renal Transplant Recipients PHASE4COMPLETED
A Randomized Controlled Pilot Trial of Indomethacin in Acute Pancreatitis PHASE3COMPLETED
Montelukast in Parkinson Disease PHASE2/PHASE3RECRUITING
Aspirin and Renal Disease Progression in Patients With Type 2 Diabetes PHASE3UNKNOWN
Lovaza's Effect on the Activation of Platelets PHASE2COMPLETED
Effect of Gemfibrozil on Serum Glycosylphosphatidylinositol (GPI) Phospholipase D and Triglycerides PHASE1COMPLETED
Assessment of Coronary Plaque Composition Using Optical Coherence Tomography PHASE1COMPLETED
Investigation of Lipoxin A4, Annexin A1 and Interleukin-1 Beta Levels in Individuals With Periodontitis. nanCOMPLETED
Plasma Free Fatty Acids Profile As A Diagnostic Tool For Acute Ischemic Stroke nanCOMPLETED
Positron Emission Tomography (PET) to Study Brain Signaling nanCOMPLETED
EPICO: (Study for the Pro-resolution of Chronic Inflammation in Obesity. Original Acronym From Spanish) nanUNKNOWN
PET Imaging of DHA Metabolism nanCOMPLETED
Mucomyst for Hepatitis C nanSUSPENDED
Molecular Markers of Human Sperm Function nanWITHDRAWN
Lipoprotein-associated Phospholipase A2 in Patients With Type 2 Diabetes nanCOMPLETED
LDL-Apheresis for FSGS CardioRenal Outcomes nanCOMPLETED
Autotaxin (ATX) as a Marker for Breast Cancer nanUNKNOWN
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
The Contribution of Lp-PLA2 Level to the Presence of Coronary Plaques in Patients With Non Alcoholic Fatty Liver Disease nanUNKNOWN
Evaluation of Plasma Sphingosine-1-Phosphate as A Diagnostic and Prognostic Biomarkers of Community-Acquired Pneumonia nanUNKNOWN
Computed Tomography and Biomarker Analysis in Diagnosing Coronary Artery Disease in Asymptomatic Patients Who Have Undergone Stem Cell Transplant nanCOMPLETED
Candida Associated Cytokines in Oral Leukoplakia nanCOMPLETED
The Association Between Post-ERCP Acute Pancreatitis and Various Genetic Mutations nanCOMPLETED
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease. nanUNKNOWN
Lp-PLA2 and Coronary Atherosclerosis in Humans nanCOMPLETED
Evaluation of Prevalence, Molecular and Genetic Backgrounds of Calcium-Based Stones Among Patients With Renal Calcular Disease in Mansoura Urology and Nephrology Center nanCOMPLETED
Collaborative Studies on the Genetics of Asthma (CSGA) nanCOMPLETED
Weathering the Storm: Lung, Heart, and Brain Vascular Rehabilitation for COVID-19 nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a PLA2G6 binder may also engage these)

ProteinNameSimilarity
P97570 0.999 P97570 →
A0A3L7I2I8 0.999 A0A3L7I2I8 →
P97819 0.998 P97819 →
A7MB89 0.972 A7MB89 →
Q8CEF1 0.972 Q8CEF1 →
Q2T9K6 0.971 Q2T9K6 →
Q5RF15 0.971 Q5RF15 →
Q6NYU2 0.968 Q6NYU2 →
Q29RM5 0.968 Q29RM5 →
Q5GIG6 0.968 Q5GIG6 →
Q9Z2G1 0.968 Q9Z2G1 →
Q7T3P8 0.968 Q7T3P8 →
Q9BSK4 0.966 Q9BSK4 →
Q9NXN4 0.966 Q9NXN4 →
Q96Q27 0.966 Q96Q27 →
Q91W86 0.965 Q91W86 →
Q5ZJV4 0.964 Q5ZJV4 →
Q6B858 0.964 Q6B858 →
Q28C34 0.964 Q28C34 →
Q4V890 0.964 Q4V890 →
Q5U2S6 0.964 Q5U2S6 →
Q96JP0 0.964 Q96JP0 →
Q2KIX2 0.963 Q2KIX2 →
HELZ Probable helicase with zinc finger domain 0.963 landscape →
Q8K0L0 0.963 Q8K0L0 →
A0FKG7 0.963 A0FKG7 →
Q7TQP6 0.963 Q7TQP6 →
Q9TS33 0.963 Q9TS33 →
Q8BPM2 0.962 Q8BPM2 →
Q32PW3 0.962 Q32PW3 →